Evidence map›Paper›PMID 42130742›Full record

ArticleFrontiers in endocrinology2026

Comparative efficacy of modified antagonist protocols combining clomiphene citrate or letrozole for ovarian stimulation in patients with normal ovarian reserve.

Huijuan Wei, Huilan Lin, Liyi Cai, Weimin Yang, Xiaoxi Li, Xiaoyan Wang, Chenyi Wang, Jing Wang, Qingqing Cheng, Kai Deng

Abstract readComparative Study
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Huijuan WeiDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Huilan LinDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Liyi CaiDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Weimin YangDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Xiaoxi LiDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Xiaoyan WangDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Chenyi WangDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Jing WangDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Qingqing ChengDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.
Kai DengDepartment of Reproductive Medicine, Hebei Maternity Hospital, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To compare the efficacy of modified gonadotropin-releasing hormone (GnRH) antagonist protocols combining clomiphene citrate (CC) or letrozole (LE) versus a conventional antagonist protocol in patients with normal ovarian reserve, aiming to reduce gonadotropin (Gn) consumption and ovarian hyperstimulation syndrome (OHSS) risk. Methods: This retrospective cohort study included 565 Results: Baseline characteristics were similar among groups. Both CC and LE groups required significantly shorter Gn duration and lower total Gn dose than the control group (both Conclusions: Modified GnRH antagonist protocols with CC or LE were associated with reduced Gn and antagonist consumption and decrease oocyte yield but were associated with higher embryo quality metrics and achieve comparable clinical pregnancy outcomes in normal ovarian reserve patients. These protocols are associated with reduced medication costs to conventional stimulation.

Indexed as

ClomipheneFertility Agents, FemaleLetrozoleOvarian ReserveOvulation InductionAdultFemaleFertilization in VitroGonadotropin-Releasing HormoneHumansOvarian Hyperstimulation SyndromePregnancyPregnancy RateRetrospective StudiesSperm Injections, IntracytoplasmicClomipheneFertility Agents, FemaleGonadotropin-Releasing HormoneLetrozoleantagonist protocolclomiphene citratein vitro fertilizationletrozolenormal ovarian reserveovarian hyperstimulation syndrome

Identifiers

PMID42130742
PMCPMC13160801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.